Charles River eyes $35M in cuts; Frontage expands its footprint;

> Charles River Laboratories ($CRL) is looking to cut about $35 million in costs from its animal model business, implementing new technologies to make its banner segment more efficient. News

> CRO Frontage has opened a new clinical research outpost in Secaucus, NJ, offering Phase II-IV services. More

> Theorem Clinical Research has recruited Icon ($ICLR) and Quintiles ($Q) veteran Scott Treiber to lead biopharma development as executive vice president. Item

Suggested Articles

Data firm Syapse has begun working with the FDA to help bring real-world evidence to bear on the agency’s decisions to approve cancer drugs.

The People-Centered Research Foundation tapped Datavant to de-identify real-world data across its national clinical research network.

Boehringer Ingelheim and MD Anderson Cancer Center have joined forces to create a “virtual” R&D hub so the pair can work on cancer drugs.